The Specialty Formulations industry on FinBizNet covers 1 listed company, with broker-view summaries, sub-industry segmentation, latest quarterly results and peer comparisons for each constituent.
| Listed companies | 1 |
|---|---|
| Combined market cap | ₹2,251 Cr |
| Median P/E (profitable companies) | 15.1 |
| Median return on equity | 11.8% |
| Companies with latest quarterly results | 1 of 1 |
| Company | Market Cap | P/E | ROE | Quarterly Revenue | Quarterly Net Profit | Quarter |
|---|---|---|---|---|---|---|
| Rossari Biotech Ossari Biotech Ltd | ₹2,251 Cr | 15.1 | 11.8% | ₹698 Cr | ₹38 Cr | Q2 FY27 |
Market data from the FinBizNet stock universe; quarterly figures in ₹ crore, parsed from each company's exchange filing (XBRL).
FinBizNet tracks 1 listed company in the Specialty Formulations industry: Rossari Biotech Ossari Biotech Ltd.
By market capitalisation, the largest Specialty Formulations companies are Rossari Biotech Ossari Biotech Ltd (₹2,251 Cr).
The 1 Specialty Formulations companies tracked on FinBizNet have a combined market capitalisation of about ₹2,251 Cr.
The median price-to-earnings ratio across 1 profitable Specialty Formulations companies is 15.1, and the median return on equity across the industry is 11.8%. Medians are shown for context only.
FinBizNet aggregates broker research, sub-industry breakdowns, quarterly results and peer-stock comparisons across the Specialty Formulations industry.